From FDA Clinical studies
Although several clinical trials are now underway to test possible therapies, the worldwide response to the COVID-19 outbreak has been largely limited to monitoring/containment. We report here that Ivermectin, an FDA-approved anti-parasitic previously shown to have broad-spectrum anti-viral activity in vitro, is an inhibitor of the causative virus (SARS-CoV-2), with a single addition to Vero-hSLAM cells 2 h post infection with SARS-CoV-2 able to effect ~5000-fold reduction in viral RNA at 48 h. Ivermectin therefore warrants further investigation for possible benefits in humans.
So a balanced conversation .I don't care either way but some people swallow anything ,like you dd.
- Forums
- ASX - By Stock
- seizing the mkt opportunity/ current mkt conditions in the usa is a good example
From FDA Clinical studiesAlthough several clinical trials are...
-
- There are more pages in this discussion • 70 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $64.73M |
Open | High | Low | Value | Volume |
2.6¢ | 2.6¢ | 2.5¢ | $34.35K | 1.322M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 114142 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 530000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 54142 | 0.026 |
11 | 1967613 | 0.025 |
8 | 1457750 | 0.024 |
4 | 1110217 | 0.023 |
6 | 1614450 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 530000 | 2 |
0.028 | 30000 | 1 |
0.030 | 84519 | 3 |
0.031 | 675001 | 2 |
0.032 | 191382 | 2 |
Last trade - 16.10pm 31/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |